STAA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

16.99

Margin Of Safety %

Put/Call OI Ratio

0.44

EPS Next Q Diff

-0.12

EPS Last/This Y

2.35

EPS This/Next Y

0.26

Price

24.21

Target Price

29.33

Analyst Recom

2.82

Performance Q

Upside

-162.2%

Beta

1.22

Ticker: STAA

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	STAA	27.78	0.36	0.00	11604
2026-07-14	STAA	27.34	0.36	0.48	11575
2026-07-15	STAA	28.47	0.36	0.05	11564
2026-07-16	STAA	28.98	0.36	0.24	11516
2026-07-17	STAA	26.42	0.36	0.90	11503
2026-07-20	STAA	23.96	0.42	0.29	10069
2026-07-21	STAA	24.28	0.42	0.65	10206
2026-07-22	STAA	24.74	0.42	0.02	10336
2026-07-23	STAA	24.22	0.42	0.16	10369
2026-07-24	STAA	23.36	0.42	0.01	10375
2026-07-27	STAA	22.96	0.43	1.99	10292
2026-07-28	STAA	22.65	0.43	0.62	10375
2026-07-29	STAA	23.89	0.44	0.37	10432
2026-07-30	STAA	24.2	0.44	0.09	10569
2026-07-31	STAA	24.38	0.44	0.31	10606
2026-08-03	STAA	24.32	0.43	0.74	10696
2026-08-04	STAA	24.1	0.44	3.00	10752
2026-08-05	STAA	22.83	0.44	1.49	10798
2026-08-06	STAA	23.13	0.45	0.15	10905
2026-08-07	STAA	24.23	0.44	0.21	11157
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	STAA	27.77	277.2	-	0.74
2026-07-14	STAA	27.33	277.2	-	0.74
2026-07-15	STAA	28.48	277.2	-	0.74
2026-07-16	STAA	28.99	277.2	-	0.74
2026-07-17	STAA	26.42	277.2	-	0.74
2026-07-20	STAA	23.99	277.2	-	0.74
2026-07-21	STAA	24.30	277.2	-	0.74
2026-07-22	STAA	24.72	277.2	-	0.74
2026-07-23	STAA	24.25	277.2	-	0.74
2026-07-24	STAA	23.37	273.4	-	0.73
2026-07-27	STAA	22.97	273.4	-	0.73
2026-07-28	STAA	22.66	273.4	-	0.73
2026-07-29	STAA	23.89	273.4	-	0.73
2026-07-30	STAA	24.24	273.4	-	0.73
2026-07-31	STAA	24.38	273.4	-	0.73
2026-08-03	STAA	24.33	273.4	-	0.73
2026-08-04	STAA	24.33	273.4	-	0.73
2026-08-05	STAA	22.85	273.4	-	0.73
2026-08-06	STAA	23.12	273.4	-	0.73
2026-08-07	STAA	24.21	273.4	-	0.73
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	STAA	3.65	-7.33	17.61
2026-07-14	STAA	3.50	-7.33	17.61
2026-07-15	STAA	3.50	-7.33	17.61
2026-07-16	STAA	3.50	-7.33	17.61
2026-07-17	STAA	3.50	-7.33	17.61
2026-07-20	STAA	3.50	-7.78	17.61
2026-07-21	STAA	3.50	-7.78	17.61
2026-07-22	STAA	3.50	-7.78	17.61
2026-07-23	STAA	3.50	-7.78	17.61
2026-07-24	STAA	3.50	-7.78	17.61
2026-07-27	STAA	3.50	-7.07	16.99
2026-07-28	STAA	3.50	-7.07	16.99
2026-07-29	STAA	3.50	-7.07	16.99
2026-07-30	STAA	3.50	-7.07	16.99
2026-07-31	STAA	3.50	-7.07	16.99
2026-08-03	STAA	3.50	-5.58	16.99
2026-08-04	STAA	3.50	-5.58	16.99
2026-08-06	STAA	3.50	-5.58	16.99
2026-08-07	STAA	3.50	-5.58	16.99
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.29

Avg. EPS Est. Current Quarter

0.22

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

3.5

Institutional Transactions

-5.58

Beta

1.22

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

85.2

Max Drawdown 5-Year %

-90.7

Target Price

29.33

P/E

Forward P/E

25.28

PEG

P/S

4.15

P/B

3.39

P/Free Cash Flow

EPS

-0.43

Average EPS Est. Cur. Y

0.73

EPS Next Y. (Est.)

0.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-7.24

Relative Volume

0.88

Return on Equity vs Sector %

-33.3

Return on Equity vs Industry %

-15.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

◆ STAA Healthcare

$24.21

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

15/25

Volume

7/15

Valuation

15/20

TP/AR

2/10

Options

6/10

RSI

43.8

Range 1M

31.8%

Sup Dist

7.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

15/30

Estimates

7/20

Inst/Vol

0/15

Options

8/10

EPS Yr

171.4%

52W%

41.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +36.8% upside

Quality

8/30

Valuation

10/30

Growth

13/25

Stability

7/10

LT Trend

0/5

Upside

+36.8%

Quality

STAA — P/E HistoricalMedical Instruments & Supplies

STAAR Surgical Company

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 921

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAA

Latest News

—

Caricamento notizie per STAA…

stock quote shares STAA – STAAR Surgical Company Stock Price stock today

news today STAA – STAAR Surgical Company stock forecast ,stock prediction 2023 2024 2025

marketwatch STAA – STAAR Surgical Company yahoo finance google finance

stock history STAA – STAAR Surgical Company invest stock market

stock prices STAA premarket after hours

ticker STAA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: STAA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y